| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |